[Journal logo]

Volume 61 
Part 11 
Pages o3953-o3955  
November 2005  

Received 12 October 2005
Accepted 27 October 2005
Online 31 October 2005

Key indicators
Single-crystal X-ray study
T = 150 K
Mean [sigma](C-C) = 0.003 Å
R = 0.050
wR = 0.129
Data-to-parameter ratio = 16.5
Details

4,7a-Bis(4-methoxyphenyl)-1,3,7-tris(4-methylphenyl)-2,3,5,6,7,7a-hexahydro-1H-pyrrolo[2,3-d]pyrimidine-2,5,6-trione

aDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, England,bDepartment of Chemistry, Yozgat Faculty of Arts and Sciences, Erciyes University, 66200-Yozgat, Turkey, and cDepartment of Physics, Yozgat Faculty of Arts and Sciences, Erciyes University, 66200-Yozgat, Turkey
Correspondence e-mail: h.adams@sheffield.ac.uk

The structure of the title compound, C41H35N3O5, is stabilized by intra- and intermolecular C-H...O hydrogen bonds.

Comment

Pyrrolo[2,3]pyrimidines are an important class of compounds that are structurally and chemically related to nucleosides and some antibiotics (Ohgi et al., 1979[Ohgi, T., Kondo, T. & Goto, T. (1979). J. Am. Chem. Soc. 101, 3629-3633.]; Tolmann et al., 1968[Tolmann, R. L., Robins, R. K. & Townsend, L. B. (1968). J. Am. Chem. Soc. 90, 524-526.]). The well known biological activity of these compounds has led to intensive investigation of their use as antitumor, anti-allergic, antiviral and anti-inflammatory agents (Hutzenlaub et al., 1972[Hutzenlaub, W., Tolman, R. L. & Robins, R. K. (1972). J. Med. Chem. 15, 879-883.]; Smith et al., 1972[Smith, C. W., Sidwell, R. W., Robins, R. K. & Tolman, R. L. (1972). J. Med. Chem. 15, 883-887.]).

In the light of this, we have synthesized and characterized the title compound, (2)[link], and have determined its structure by X-ray analysis.

[Scheme 1]

Fig. 1[link] shows the molecular structure of (2)[link], with the atomic numbering scheme. The six-membered non-aromatic ring (C2/C1/N1/C5/N2/C6) has a total puckering amplitude of 0.532 (3) Å (Cremer & Pople, 1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]) and a boat conformation [[varphi] = 179.5 (4)° and [theta] = 105.0 (5)°]. The five-membered aromatic ring (C1-C4/N3) and the five benzene rings (C7-C12, C13-C18, C19-C24, C25-C30 and C31-C36) are each essentially planar, with r.m.s. deviations of 0.0296 (13), 0.0104 (14), 0.0069 (15), 0.0067 (15), 0.046 (16) and 0.126 (15) Å, respectively. The bond lengths and angles are in agreement with reported literature values (Allen et al., 1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L. & Orpen, A. G. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

The structure is stabilized by intra- and intermolecular C-H...O hydrogen bonds (Table 1[link]). In the crystal structure, the C-H...O intermolecular hydrogen bonds link the molecules into dimers which are stacked along the b axis (Fig. 2[link]).

[Figure 1]
Figure 1
The molecular structure of (2)[link], with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms have been omitted.
[Figure 2]
Figure 2
Packing diagram of (2)[link]; C-H...O hydrogen bonds are shown as dashed lines.

Experimental

Compound (1) was prepared from the cyclocondensation reaction that occurs between p,p'-dimethoxydibenzoylketene and oxalyl chloride (Hökelek et al., 2002[Hökelek, T., Saripinar, E., Yildirim, I., Akkurt, M. & Akçamur, Y. (2002). Acta Cryst. E58, o30-o32.]). Compound (2) was obtained from (1) (1.0 g, 2.96 mmol) by reaction with an excess of p-tolyl isocyanate in a 25 ml round-bottomed flask equipped with a calcium chloride tube. The mixture was heated at 338 K for 24 h. After cooling to room temperature, the residue was triturated with anhydrous diethyl ether, and the crude product was recrystallized from ethanol (yield 1.26 g, 66%; m.p. 475 K). IR (KBr, cm-1): [upsilon] 1727 (C3-O1), 1709 (C4-O2), 1684 (C5-O3); 1H NMR (CDCl3, p.p.m..): [delta] 7.64-6.04 (m, 20H, Ar-H), 3.88, 3.77 (s, 6H, CH3O), 2.25, 2.18, 2.15 (s, 9H, Ar-CH3); 13C NMR (CDCl3, p.p.m..): [delta] 178.51 (C3-O1), 165.58 (C4-O2), 164.47 (C5-O3), 162.35-115.52 (C=C, arom. and aliph.), 81.36 (N1-C1-N2), 57.50 (O4-C38), 57.28 (O5-C37), 23.00, 22.94, 22.92 (Ar-CH3). Analysis calculated for C41H35N3O5: C 75.80, H 5.39, N 6.47%; found: C 76.02, H 5.69, N 6.22%.

Crystal data
  • C41H35N3O5

  • Mr = 649.72

  • Triclinic, [P \overline 1]

  • a = 10.1797 (12) Å

  • b = 12.5347 (14) Å

  • c = 13.6855 (16) Å

  • [alpha] = 107.999 (2)°

  • [beta] = 99.985 (2)°

  • [gamma] = 90.504 (2)°

  • V = 1632.0 (3) Å3

  • Z = 2

  • Dx = 1.322 Mg m-3

  • Mo K[alpha] radiation

  • Cell parameters from 3062 reflections

  • [theta] = 4.7-50.5°

  • [mu] = 0.09 mm-1

  • T = 150 (2) K

  • Block, yellow

  • 0.38 × 0.21 × 0.10 mm

Data collection
  • Bruker SMART 1000 CCD area-detector diffractometer

  • [omega] scans

  • Absorption correction: multi-scan(SADABS; Bruker, 1997[Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.])Tmin = 0.968, Tmax = 0.991

  • 18940 measured reflections

  • 7331 independent reflections

  • 4028 reflections with I > 2[sigma](I)

  • Rint = 0.054

  • [theta]max = 27.6°

  • h = -13 [rightwards arrow] 13

  • k = -16 [rightwards arrow] 16

  • l = -17 [rightwards arrow] 17

Refinement
  • Refinement on F2

  • R[F2 > 2[sigma](F2)] = 0.050

  • wR(F2) = 0.129

  • S = 0.98

  • 7331 reflections

  • 445 parameters

  • H-atom parameters constrained

  • w = 1/[[sigma]2(Fo2) + (0.054P)2 + 0.1342P] where P = (Fo2 + 2Fc2)/3

  • ([Delta]/[sigma])max < 0.001

  • [Delta][rho]max = 0.26 e Å-3

  • [Delta][rho]min = -0.25 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)[link]

D-H...A D-H H...A D...A D-H...A
C9-H9A...O1i 0.95 2.55 3.409 (3) 150
C11-H11A...O2ii 0.95 2.53 3.158 (3) 123
C18-H18A...O3 0.95 2.58 2.927 (3) 102
C30-H30A...O2 0.95 2.55 2.928 (3) 104
C32-H32A...N1 0.95 2.51 2.858 (3) 102
C39-H39C...O5iii 0.98 2.48 3.422 (3) 160
C40-H40C...O4iv 0.98 2.54 3.341 (3) 139
Symmetry codes: (i) -x, -y+1, -z; (ii) -x+1, -y+1, -z; (iii) x-1, y, z; (iv) x+1, y, z+1.

H atoms were positioned geometrically [0.95 (CH) and 0.98 Å (CH3)] and constrained to ride on their parent atoms, with Uiso(H) values of 1.2 (1.5 for methyl) times Ueq.

Data collection: SMART (Bruker, 1997[Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 1997[Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SHELXTL (Bruker, 1997[Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXL97 and SHELXS97. University of Göttingen, Germany.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997[Sheldrick, G. M. (1997). SHELXL97 and SHELXS97. University of Göttingen, Germany.]); molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L. & Orpen, A. G. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19. [CrossRef] [ChemPort]
Bruker (1997). SMART, SAINT, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358. [CrossRef] [ChemPort]
Hökelek, T., Saripinar, E., Yildirim, I., Akkurt, M. & Akçamur, Y. (2002). Acta Cryst. E58, o30-o32. [details]
Hutzenlaub, W., Tolman, R. L. & Robins, R. K. (1972). J. Med. Chem. 15, 879-883. [PubMed] [CrossRef] [ChemPort]
Ohgi, T., Kondo, T. & Goto, T. (1979). J. Am. Chem. Soc. 101, 3629-3633. [CrossRef] [ChemPort]
Sheldrick, G. M. (1997). SHELXL97 and SHELXS97. University of Göttingen, Germany.
Smith, C. W., Sidwell, R. W., Robins, R. K. & Tolman, R. L. (1972). J. Med. Chem. 15, 883-887. [PubMed] [CrossRef] [ChemPort]
Tolmann, R. L., Robins, R. K. & Townsend, L. B. (1968). J. Am. Chem. Soc. 90, 524-526. [PubMed] [CrossRef]


Acta Cryst (2005). E61, o3953-o3955   [ doi:10.1107/S1600536805035191 ]